Skip to main content
. 2023 Jun 29;32(16):2545–2557. doi: 10.1093/hmg/ddad103

Figure 2.

Figure 2

The beneficial and detrimental roles of the PERK signaling pathway in AD, PD, HD, ALS, MS and cancer.